TissueGene-C(Low dose)

BIOLOGICAL2 trials

Sponsors

Kolon Life Science

Conditions

Degenerative Arthritis

Phase 1

Safety and Biological Efficacy Study of TisssueGene-C to Degenerative Arthritis

CompletedNCT02341391

Kolon Life ScienceDegenerative Arthritis

Start: 2007-02-28End: 2008-09-30Updated: 2018-07-05

Phase 2

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

CompletedNCT02341378

Kolon Life ScienceDegenerative Arthritis

Start: 2009-08-31End: 2010-10-31Updated: 2015-01-22